Key Highlights

• Morgan Stanley & Co. International plc filed a Form 38.5(a) (EPT/RI) dealing disclosure on DCC plc (LSE:DCC) under the Irish Takeover Rules.

• The form names the connected party as an Energy Capital Partners, LLC and Kohlberg Kravis Roberts & Co. L.P. (ECP/KKR) consortium.

• Dealings on 1 June 2026 included purchases of 79,287 and 3,268 shares and sales of 80,894 shares, plus numerous CFD transactions.

• Prices were quoted predominantly around 59.49–60.50 GBP per share, reflecting DCC's high share price, with a small number near 80.02 USD.

• The filing confirms a named consortium connection in a client-serving capacity; it does not disclose any offer price, terms or outcome.

Introduction

The naming of a specific bidding consortium in a Takeover-related filing can sharpen investor focus considerably — and that is exactly what the Form 38.5(a) dealing disclosure filed by Morgan Stanley & Co. International plc in respect of DCC plc (LSE:DCC) does. Published on 2 June 2026 and covering dealings on 1 June 2026, the disclosure identifies Morgan Stanley as a connected exempt principal trader and names the party with which it is connected as an Energy Capital Partners, LLC and Kohlberg Kravis Roberts & Co. L.P. consortium.

For followers of London Stock Exchange filings, this raises an obvious question: what does it mean that a major investment bank is disclosing dealings while connected with an ECP/KKR consortium in relation to a FTSE 100 services group? This article concentrates on that consortium connection — what it signals, what it does not, and how to read the dealing detail accurately. As with all such disclosures, it is critical to be precise: the form names a consortium and discloses dealings, but it does not set out any offer price, terms or outcome, and none should be inferred.

DCC plc (LSE:DCC): Company Background

DCC plc is a FTSE 100 international sales, marketing and support services group with Irish heritage and a primary London listing. It is organised around three divisions: DCC Energy, covering the sale, distribution and servicing of energy products and solutions; DCC Healthcare, serving the health and beauty markets; and DCC Technology, distributing and supporting technology products.

This diversified, services-led structure has historically given DCC exposure across multiple end-markets and geographies, supported by a reputation for disciplined capital allocation and acquisition-led growth. Among UK shares, DCC stands out as one of the more internationally diversified names, and its cash-generative model has long made it a recognised constituent of the UK stock market's senior index.

The combination of scale, diversification and steady cash generation is part of what makes a group like DCC interesting to a wide range of investors — and, more broadly, the kind of business that can attract the attention of large financial sponsors. That context is relevant to understanding why a private-equity consortium connection might feature in a dealing disclosure, though it is the formal disclosures, not background, that determine the facts of any situation.

What the RNS Announcement Says: Plain-English Summary

The announcement is a Form 38.5(a) (EPT/RI), the Irish Takeover Rules dealing disclosure used by a connected exempt principal trader with recognised intermediary status. Morgan Stanley & Co. International plc is the exempt principal trader, DCC plc is the offeree to which the form relates, and the party with which Morgan Stanley is connected is identified as the Energy Capital Partners, LLC and Kohlberg Kravis Roberts & Co. L.P. consortium.

The dealings are dated 1 June 2026 and the disclosure was published on 2 June 2026, in DCC 0.25 ordinary shares. On the share dealings, the form records purchases of 79,287 shares at a high of 60.4000 GBP and a low of 59.4952 GBP, further purchases of 3,268 shares at 80.5445 USD high and 80.0218 USD low, and sales of 80,894 shares at 60.5000 GBP high and 59.4881 GBP low. In addition, the form discloses numerous CFD (cash-settled derivative) transactions in the same 0.25 ordinary shares on 1 June 2026, increasing and reducing both long and short positions, at prices predominantly in the 59.4881–60.5000 GBP range and a small number around 80.02 USD. The named contact is Claire Gordon.

A key point of interpretation: the share prices are quoted in GBP per share — in the tens of pounds — because DCC is a high-priced share. What the form does not contain is any offer price, deal value, premium or terms, and it does not confirm that any offer will be made by the consortium or that any transaction will succeed.

The Most Important Details

The standout feature of this filing is the explicit naming of the connected party as an Energy Capital Partners and KKR consortium. Energy Capital Partners is a well-known investor focused on energy and infrastructure, while KKR is one of the world's largest global investment firms. The fact that a Form 38.5(a) discloses Morgan Stanley as connected with such a consortium is a concrete, named data point in the public record.

However, the nature of the disclosure must be kept in view. Morgan Stanley is acting as a connected exempt principal trader with recognised intermediary status, dealing in a client-serving capacity. The substantial purchases (79,287 and 3,268 shares) and sales (80,894 shares), together with the numerous CFD transactions adjusting long and short positions, are consistent with intermediary and hedging activity rather than a simple directional accumulation by the consortium itself.

The CFD detail is notable. Cash-settled derivatives allow exposure to be taken or hedged without holding the underlying shares outright, and the form shows both increases and reductions in long and short positions across the day. The prices — clustered around 59.49 to 60.50 GBP, with a few near 80.02 USD — again reflect DCC's elevated share price. Read together, the figures describe active, two-way intermediary dealing connected with the consortium, not a disclosed stake purchase on agreed terms.

Why Investors May Be Watching DCC plc (LSE:DCC)

The naming of an ECP/KKR consortium understandably heightens investor interest in DCC (LSE:DCC). When two prominent financial sponsors are identified as the party connected with a major bank's dealing disclosure during an offer period, shareholders following their investor update routine will naturally take note. It indicates that the offer period involves a specifically named private-equity consortium, at least in the connection disclosed on this form.

That said, the connection does not equate to a confirmed offer. The Form 38.5(a) discloses dealings and a connection; it does not disclose whether the consortium has made, or will make, a firm offer, nor on what terms, nor whether any such offer would be recommended or successful. Investors should be careful to separate the fact of a named consortium connection from any assumption about deal terms or outcomes.

The constructive reading is that the disclosure regime is surfacing relevant, named information in a transparent way. For the substance of any potential transaction, the authoritative sources are the formal RNS announcements from DCC and from the consortium or its bidding vehicle, not the dealing forms filed by connected intermediaries.

Market Context

The UK stock market has seen recurring interest from private-equity and infrastructure investors in London-listed companies, particularly those with strong cash generation and diversified operations. Within that environment, the involvement of large sponsors such as KKR and specialist investors such as Energy Capital Partners in offer periods is closely followed in stock market news.

For DCC specifically, an offer period triggers extensive disclosure obligations under the Irish Takeover Rules, given the company's Irish incorporation, alongside the broader transparency expectations associated with a primary London listing. The dealing disclosures that accompany such a period — including EPT/RI filings like Morgan Stanley's — are a standard feature of that regime and reflect process rather than a series of independent strategic signals.

This market context does not point to any particular DCC share price outlook. The presence of a named consortium and active intermediary dealing is part of the normal architecture of an offer period. The share price will ultimately be shaped by whether any firm offer emerges, on what terms, and how the board and shareholders respond, as well as by the company's fundamentals and wider market conditions.

Industry Context

DCC's three divisions sit in distinct industries. Energy distribution and services are influenced by demand patterns, the energy transition and regulation — areas of particular relevance given Energy Capital Partners' focus on energy and infrastructure. Healthcare services respond to health and beauty market trends, while technology distribution follows product cycles and channel demand.

For financial sponsors, diversified, cash-generative services groups can be attractive because of their steady cash flows and the potential to support value-creation strategies. The named involvement of an energy-focused investor alongside a global private-equity firm is consistent with interest in a group that has a significant energy distribution footprint, though the form itself articulates no rationale and none should be assumed beyond the disclosed facts.

For investors weighing the industry backdrop, the essential point is that DCC's operating businesses continue to function across energy, healthcare and technology regardless of corporate-activity developments. Their performance will remain central to any assessment of the company, whatever the outcome of the offer period.

Potential Opportunities

The transparency value of this filing is significant: it places on the public record that Morgan Stanley is connected with a specifically named ECP/KKR consortium and discloses the related dealing activity. That level of disclosure helps all shareholders understand the landscape of an offer period on an equal informational basis.

For those assessing DCC (LSE:DCC) fundamentally, the longer-term considerations remain the strength of its energy, healthcare and technology divisions, its capital discipline and its cash generation. These factors would be relevant under any ownership scenario and are independent of the dealing form itself.

Nonetheless, it would be a mistake to translate a named consortium connection into an assumption of a successful or value-accretive offer. The form discloses no terms and no outcome. Any genuine opportunity assessment must rest on the company's fundamentals and on the formal disclosures that would set out the substance of any transaction — not on the existence of a dealing disclosure.

Key Risks and Uncertainties

The central uncertainty is that, despite naming a consortium, the Form 38.5(a) reveals nothing about offer terms or outcome. There is no disclosed bid price, no deal value and no confirmation that the ECP/KKR consortium has made or will make a firm offer, or that any offer would succeed. Treating a named connection as equivalent to a confirmed transaction would be reading far beyond the document.

Offer periods involving private-equity consortia can be complex and conditional. Any potential offer could be subject to financing, due diligence, regulatory and competition considerations, and ultimately to board and shareholder decisions. Consortia can also change in composition or withdraw. The DCC share price during this period may be volatile and sentiment-driven, and the pattern of dealing disclosures is not a reliable predictor of outcome.

The underlying business risks also persist: demand cycles across energy, healthcare and technology distribution, integration and execution risk, currency exposure and macroeconomic conditions. These remain relevant to any balanced view of DCC and should not be overshadowed by takeover speculation.

What Could Move the Share Price Next

Several developments could influence sentiment around DCC (LSE:DCC). The most material would be any formal RNS announcement clarifying whether the ECP/KKR consortium has made a firm offer and on what terms. Such announcements — not intermediary dealing forms — would carry the substance of any transaction and any associated conditions.

Continued dealing disclosures, including further EPT/RI filings and CFD activity, are likely throughout the offer period and maintain transparency without, in themselves, indicating direction. Statements from the DCC board, any Takeover Panel timetable milestones, and the company's trading performance would all be relevant, as would the broader appetite of private-equity investors for UK-listed assets.

This article does not forecast the direction of the DCC share price, and no reader should infer one from a dealing disclosure or a named consortium connection. The disciplined approach is to follow the full sequence of official disclosures and assess each on its factual merits.

Long-Term Outlook

Over the long term, DCC's prospects will be driven by the performance of its energy, healthcare and technology divisions, its capital allocation and its cash generation. These fundamentals will endure regardless of how the current offer period, and any consortium interest, ultimately resolves.

The named involvement of an ECP/KKR consortium introduces a specific dimension of uncertainty that may be settled in more than one way — including the possibility that no firm offer emerges on terms some might expect. Whatever the outcome, the long-term investment case for DCC will rest on its operating businesses and strategic execution, not on the mechanics of any single dealing disclosure.

For now, the Morgan Stanley Form 38.5(a) is best read as a transparent, factual record: it names a consortium connection and discloses client-serving dealings, but it is silent on offer terms. That precise reading is the appropriate one.

Conclusion

The Morgan Stanley Form 38.5(a) on DCC plc (LSE:DCC) is notable for explicitly naming an Energy Capital Partners and KKR consortium as the connected party, and for disclosing substantial client-serving dealings in DCC shares and CFDs on 1 June 2026. It is a concrete, named entry in the public record of DCC's offer period.

Yet for investors tracking UK shares, FTSE stocks and the broader UK stock market, the essential discipline is interpretive precision. A named consortium connection and active intermediary dealing do not amount to a confirmed offer, agreed terms, or a guaranteed outcome. The substance of any transaction will be set out in formal RNS announcements from DCC and the consortium — and that is where investors should look, while reading the original filing in full and avoiding premature conclusions about the share price outlook.